Boston Scientific Cardiac Diagnostics

Activity by year

20252026

Contract

Jun 4, 2025CONTRACT$45.0M
Bittium Biosignals signs supply agreement with Boston Scientific for ECG devices
Bittium Biosignals, a subsidiary of Bittium Corporation, has signed an agreement with Boston Scientific Cardiac Diagnostics to supply electrocardiogram measuring devices for cardiac arrhythmia monitoring, valued at approximately USD 30-45 million, with revenues accruing during 2025-2028.
Bittium Biosignals Ltd Boston Scientific Cardiac Diagnostics customer #Medical Devices news.cision.com

Suppliers

Loading…